Home/Filings/4/0001062993-25-012333
4//SEC Filing

Saadi Ryan H. 4

Accession 0001062993-25-012333

CIK 0001860871other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:49 PM ET

Size

5.6 KB

Accession

0001062993-25-012333

Insider Transaction Report

Form 4
Period: 2025-06-27
Saadi Ryan H.
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common Stock

    2025-06-27+8,000,000124,814,453.322 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    193,924
Footnotes (1)
  • [F1]Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments commencing on June 27, 2032, provided that the reporting person remains in service with the Issuer at such dates.

Issuer

Tevogen Bio Holdings Inc.

CIK 0001860871

Entity typeother

Related Parties

1
  • filerCIK 0002011728

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:49 PM ET
Size
5.6 KB